Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies.

4 points crucial to the nimble regulation of GenAI
With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.
FDA recalls infant incubators due to risk of door falling off
A loose screw on the Giraffe OmniBed is to blame. With updated use instructions and repairs, the incubators are safe to use.
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT
CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.
Kentucky AG launches criminal probe after conscious man nearly has organs harvested
Three years ago Anthony Hoover was declared brain dead—until he woke up on the operating room table, moments before his organs were removed. His story has spurred a criminal investigation by Kentucky's attorney general.
FDA announces Class I recall of ventilators after 3 patient injuries
An unexpected nickel coating on the breathing circuits of Percussionaire Phasitron 5 ventilators is being blamed for the recall. The FDA is asking providers to stop using them immediately.

Adopting AI no walk in the park for healthcare providers

The rise of AI is an exciting change for healthcare providers all over the world, but implementing these groundbreaking technologies still comes with its fair share of significant challenges.

October 18, 2019

AMA, industry groups urge Congress to act on surprise billing

The American Medical Association has joined forces with 110 other healthcare industry groups representing hundreds of thousands of physicians to urge Congress to find a balanced approach to surprise medical billing legislation.

October 17, 2019

3 key ways imaging professionals can influence the implementation of AI

Medical imaging professionals and radiation experts are in a position to play a significant role as AI technologies continue to evolve, according to a new commentary published in the Journal of Medical Imaging and Radiation Sciences.

October 17, 2019

Drug prices surge thanks to new product launches

New drug launches are pushing overall drug prices higher, according to an analysis by 46Brooklyn. Drugmakers may not be increasing existing drug prices as high as they once did, but new drug launches are more than making up for that change, the report found.

October 17, 2019

Former Cigna exec warns of lobbying power by insurance industry

A former insurance executive is speaking up against the lobbying power of the health insurance industry as the issue of healthcare reform in the 2020 election heats up in the Democratic debates.

October 17, 2019

Healthcare providers say regulatory burdens are rising

Despite the Trump administration’s battle cry to cut regulation and reduce paperwork for healthcare organizations, more medical practices say regulatory burdens are worse. And they’ve named prior authorization as the worst regulatory offender.

October 16, 2019

Physician-led ACOs are top performers

Physician-led accountable care organizations (ACOs) outperform those led by hospitals, according to a new report from Avalere Health. Not only did physician-led ACOs outperform by a significant margin, but all ACOs had higher savings the longer they were around.

October 16, 2019

Bipartisan Policy Center hosts public event on the future of AI

The Bipartisan Policy Center (BPC) hosted an open discussion on the future of AI on Wednesday, Oct. 16, in Washington, D.C. Topics included AI’s impact on the economy and how public policies may change in the near future as a response to these evolving technologies.

October 16, 2019

Around the web

AI in Healthcare

4 points crucial to the nimble regulation of GenAI

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Cardiovascular Business

Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more.

Cardiovascular Business

Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.